Table 1 . summary Distribution of all variables ,Groupwise
| variable | FENTOFOL | KETOFOL | P value | |
|---|---|---|---|---|
| AGE | Mean (SD) | 39.9 (9.8) | 40.9 (11.0) | 0.341 |
| SEX | Female | 21 (52.5) | 23 (57.5) | 0.653 |
| Male | 19 (47.5) | 17 (42.5) | ||
| MOUTH_OPENING | Full | 35 (87.5) | 37 (92.5) | 0.456 |
| Partial | 5 (12.5) | 3 (7.5) | ||
| COUGHING | Mild | 2 (5.0) | 4 (10.0) | 0.396 |
| Nil | 38 (95.0) | 36 (90.0) | ||
| SWALLOWING | Nil | 40 (100.0) | 40 (100.0) | NA |
| EASE_OF_INSERTION | Difficult | 1 (2.5) | 2 (5.0) | 0.556 |
| Easy | 39 (97.5) | 38 (95.0) | ||
| MOVEMENT | Mild | 12 (30.0) | 14 (35.0) | 0.556 |
| Nil | 27 (67.5) | 26 (65.0) | ||
| Severe | 1 (2.5) | 0 (0.0) | ||
| LARYNGOSPASM | Nil | 40 (100.0) | 40 (100.0) | NA |
| APNEA | Apnea | 35 (87.5) | 0 (0.0) | <0.001 |
| No_Apnea | 5 (12.5) | 40 (100.0) | ||
| ADDITIONAL_PROPOFOL_REQUIRED | No | 29 (72.5) | 37 (92.5) | 0.019 |
| Yes | 11 (27.5) | 3 (7.5) | ||
| LMA_INSERTION_SCORE | 6 | 12 (30.0) | 6 (15.0) | 0.020 |
| 7 | 23 (57.5) | 19 (47.5) | ||
| 8 | 1 (2.5) | 10 (25.0) | ||
| 9 | 4 (10.0) | 5 (12.5) | ||
| SBP_BEFORE_INDUCTION | Mean (SD) | 128.8 (8.7) | 125.5 (8.2) | 0.124 |
| SBP_AFTER_INTERVENTION | Mean (SD) | 127.6 (8.9) | 128.0 (8.6) | 0.992 |
| SBP_AFTER_PROPOFOL | Mean (SD) | 112.8 (9.8) | 118.3 (8.9) | 0.013 |
| SBP_AFTER_LMA | Mean (SD) | 104.7 (9.3) | 133.6 (11.4) | <0.001 |
| SBP_1_MIN | Mean (SD) | 97.4 (8.4) | 125.9 (8.6) | <0.001 |
| SBP_2_MIN | Mean (SD) | 106.8 (10.1) | 124.6 (9.5) | <0.001 |
| SBP_3_MIN | Mean (SD) | 108.9 (9.6) | 119.3 (8.5) | <0.001 |
| DBP_1_MIN | Mean (SD) | 70.1 (4.2) | 86.6 (4.2) | <0.001 |
| DBP_2_MIN | Mean (SD) | 74.8 (4.7) | 86.3 (4.6) | <0.001 |
| DBP_3_MIN | Mean (SD) | 78.4 (4.8) | 85.5 (4.4) | <0.001 |
| DBP_AFTER_INTERVENTION | Mean (SD) | 86.3 (5.2) | 88.7 (4.3) | 0.066 |
| DBP_AFTER_LMA | Mean (SD) | 72.8 (5.1) | 87.7 (5.5) | <0.001 |
| DBP_AFTER_PROPOFOL | Mean (SD) | 80.0 (4.8) | 83.5 (4.8) | 0.002 |
| DBP_BEFORE_INDUCTION | Mean (SD) | 89.2 (4.1) | 89.0 (4.1) | 0.996 |
| PR_BEFORE_INDUCTION | Mean (SD) | 71.1 (8.6) | 72.1 (8.3) | 0.643 |
| PR_AFTER_INTERVENTION | Mean (SD) | 68.0 (8.9) | 78.4 (8.5) | <0.001 |
| PR_AFTER_PROPOFOL | Mean (SD) | 64.4 (9.8) | 73.8 (9.0) | <0.001 |
| PR_AFTER_LMA | Mean (SD) | 75.1 (9.2) | 106.0 (11.4) | <0.001 |
| PR_1_MIN | Mean (SD) | 67.9 (8.5) | 88.4 (8.6) | <0.001 |
| PR_2_MIN | Mean (SD) | 64.2 (10.2) | 81.2 (9.5) | <0.001 |
| PR_3_MIN | Mean (SD) | 59.4 (9.6) | 75.0 (8.5) | <0.001 |
| MAP_BEFORE_INDUCTION | Mean (SD) | 89.2 (4.1) | 89.0 (4.1) | 0.996 |
| MAP_AFTER_INTERVENTION | Mean (SD) | 86.3 (5.2) | 88.7 (4.3) | 0.066 |
| MAP_AFTER_PROPOFOL | Mean (SD) | 80.0 (4.8) | 83.5 (4.8) | 0.002 |
| MAP_AFTER_LMA | Mean (SD) | 72.8 (5.1) | 87.7 (5.5) | <0.001 |
| MAP_1_MIN | Mean (SD) | 70.1 (4.2) | 86.6 (4.2) | <0.001 |
| MAP_2_MIN | Mean (SD) | 74.8 (4.7) | 86.3 (4.6) | <0.001 |
| MAP_3_MIN | Mean (SD) | 78.4 (4.8) | 85.5 (4.4) | <0.001 |
| RR_BEFORE_INDUCTION | 11 | 7 (17.5) | 13 (32.5) | 0.129 |
| 12 | 28 (70.0) | 18 (45.0) | ||
| 13 | 5 (12.5) | 8 (20.0) | ||
| 14 | 0 (0.0) | 1 (2.5) | ||
| RR_AFTER_INTERVENTION | 8 | 2 (5.0) | 0 (0.0) | <0.001 |
| 9 | 4 (10.0) | 0 (0.0) | ||
| 10 | 6 (15.0) | 0 (0.0) | ||
| 11 | 7 (17.5) | 5 (12.5) | ||
| 12 | 8 (20.0) | 30 (75.0) | ||
| 13 | 4 (10.0) | 5 (12.5) | ||
| 14 | 5 (12.5) | 0 (0.0) | ||
| 15 | 3 (7.5) | 0 (0.0) | ||
| 16 | 1 (2.5) | 0 (0.0) | ||
| RR_AFTER_PROPOFOL | 9 | 2 (5.0) | 0 (0.0) | 0.092 |
| 10 | 6 (15.0) | 2 (5.0) | ||
| 11 | 6 (15.0) | 15 (37.5) | ||
| 12 | 11 (27.5) | 14 (35.0) | ||
| 13 | 10 (25.0) | 5 (12.5) | ||
| 14 | 4 (10.0) | 4 (10.0) | ||
| 15 | 1 (2.5) | 0 (0.0) | ||
| RR_AFTER_LMA | 11 | 1 (2.5) | 0 (0.0) | 0.001 |
| 12 | 3 (7.5) | 1 (2.5) | ||
| 13 | 12 (30.0) | 4 (10.0) | ||
| 14 | 13 (32.5) | 3 (7.5) | ||
| 15 | 7 (17.5) | 10 (25.0) | ||
| 16 | 3 (7.5) | 11 (27.5) | ||
| 17 | 1 (2.5) | 5 (12.5) | ||
| 18 | 0 (0.0) | 4 (10.0) | ||
| 19 | 0 (0.0) | 2 (5.0) | ||
| RR_1_MIN | 12 | 11 (27.5) | 0 (0.0) | <0.001 |
| 13 | 21 (52.5) | 4 (10.0) | ||
| 14 | 8 (20.0) | 12 (30.0) | ||
| 15 | 0 (0.0) | 14 (35.0) | ||
| 16 | 0 (0.0) | 7 (17.5) | ||
| 17 | 0 (0.0) | 3 (7.5) | ||
| RR_2_MIN | 11 | 13 (32.5) | 0 (0.0) | <0.001 |
| 12 | 19 (47.5) | 5 (12.5) | ||
| 13 | 6 (15.0) | 33 (82.5) | ||
| 14 | 2 (5.0) | 2 (5.0) | ||
| RR_3_MIN | 10 | 3 (7.5) | 0 (0.0) | 0.013 |
| 11 | 19 (47.5) | 11 (27.5) | ||
| 12 | 10 (25.0) | 21 (52.5) | ||
| 13 | 5 (12.5) | 8 (20.0) | ||
| 14 | 3 (7.5) | 0 (0.0) | ||
| SpO2_BEFORE_INDUCTION | 97 | 0 (0.0) | 1 (2.5) | 0.446 |
| 98 | 5 (12.5) | 3 (7.5) | ||
| 99 | 6 (15.0) | 10 (25.0) | ||
| 100 | 29 (72.5) | 26 (65.0) | ||
| SpO2_AFTER_INTERVENTION | 97 | 1 (2.5) | 0 (0.0) | 0.767 |
| 98 | 3 (7.5) | 4 (10.0) | ||
| 99 | 6 (15.0) | 6 (15.0) | ||
| 100 | 30 (75.0) | 30 (75.0) | ||
| SpO2_AFTER_PROPOFOL | 98 | 1 (2.5) | 1 (2.5) | 0.767 |
| 99 | 14 (35.0) | 11 (27.5) | ||
| 100 | 25 (62.5) | 28 (70.0) | ||
| SpO2_AFTER_LMA | 97 | 1 (2.5) | 0 (0.0) | 0.234 |
| 98 | 5 (12.5) | 1 (2.5) | ||
| 99 | 7 (17.5) | 10 (25.0) | ||
| 100 | 27 (67.5) | 29 (72.5) | ||
| SpO2_1_MIN | 97 | 2 (5.0) | 0 (0.0) | 0.126 |
| 98 | 3 (7.5) | 0 (0.0) | ||
| 99 | 11 (27.5) | 10 (25.0) | ||
| 100 | 24 (60.0) | 30 (75.0) | ||
| SpO2_2_MIN | 97 | 1 (2.5) | 0 (0.0) | 0.060 |
| 98 | 4 (10.0) | 0 (0.0) | ||
| 99 | 7 (17.5) | 14 (35.0) | ||
| 100 | 28 (70.0) | 26 (65.0) | ||
| SpO2_3_MIN | 97 | 2 (5.0) | 0 (0.0) | 0.046 |
| 98 | 4 (10.0) | 0 (0.0) | ||
| 99 | 8 (20.0) | 5 (12.5) | ||
| 100 | 26 (65.0) | 35 (87.5) |
Distribution of Demographic Variables in Our Population
Fig.1 Plot of Age distribution across Groups
The Dodged bar chart above represents individual counts representing frequency of age_grp categories 30-40,50-60,40-50,20-30,10-20 and 60-70 in categories FENTOFOL and KETOFOL Subgroups. Age Group group 30-40 has highest percentage 16/40 ( 40 % ) in group FENTOFOL . Subgroup 40-50 has highest percentage 15/40 ( 37.5 % ) in group KETOFOL . To formally check for association between groups we performed pearson chi-square test .
we found a Non-significant association between age_grp and DRUG. The chi-square statistic was 5.44 . The degree of freedom was 5 and P value was 0.36 .Contingency and Proportion table are shown below.
Table 2
| DRUG | age_grp | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| FENTOFOL | 10-20 | 1 | 1/40 ( 2.5 %) | 0.27% - 11.09% |
| FENTOFOL | 20-30 | 5 | 5/40 ( 12.5 %) | 4.93% - 25.25% |
| FENTOFOL | 30-40 | 16 | 16/40 ( 40 %) | 25.95% - 55.44% |
| FENTOFOL | 40-50 | 13 | 13/40 ( 32.5 %) | 19.6% - 47.84% |
| FENTOFOL | 50-60 | 4 | 4/40 ( 10 %) | 3.47% - 22.04% |
| FENTOFOL | 60-70 | 1 | 1/40 ( 2.5 %) | 0.27% - 11.09% |
| KETOFOL | 10-20 | 3 | 3/40 ( 7.5 %) | 2.16% - 18.68% |
| KETOFOL | 20-30 | 5 | 5/40 ( 12.5 %) | 4.93% - 25.25% |
| KETOFOL | 30-40 | 9 | 9/40 ( 22.5 %) | 11.76% - 37.06% |
| KETOFOL | 40-50 | 15 | 15/40 ( 37.5 %) | 23.79% - 52.95% |
| KETOFOL | 50-60 | 8 | 8/40 ( 20 %) | 9.94% - 34.22% |
Table 3
| FENTOFOL | KETOFOL | |
|---|---|---|
| 10-20 | 1 | 3 |
| 20-30 | 5 | 5 |
| 30-40 | 16 | 9 |
| 40-50 | 13 | 15 |
| 50-60 | 4 | 8 |
| 60-70 | 1 | 0 |
Figure 2 Sex Distribution in Our Population
The Dodged bar chart above represents individual counts representing frequency of SEX categories Female and Male in categories FENTOFOL and KETOFOL . To formally check for association between groups we performed pearson chi-square test
we found a Non-significant association between SEX and CO-INDUCTION Agent. The chi-square statistic was 0.05 . The degree of freedom was 1 and P value was 0.82 .Contingency and Proportion table are shown below
Table 4
| DRUG | SEX | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| FENTOFOL | Female | 21 | 21/40 ( 52.5 %) | 37.3% - 67.35% |
| FENTOFOL | Male | 19 | 19/40 ( 47.5 %) | 32.65% - 62.7% |
| KETOFOL | Female | 23 | 23/40 ( 57.5 %) | 42.1% - 71.85% |
| KETOFOL | Male | 17 | 17/40 ( 42.5 %) | 28.15% - 57.9% |
Table 5
| FENTOFOL | KETOFOL | |
|---|---|---|
| Female | 21 | 23 |
| Male | 19 | 17 |
Figure 3 Trace-Plot Of variation in Systolic BP with Time in FentoFol and Ketofol groups
This is a trace-plot of variation in Systolic BP (on Y axis) with passage of of time of LMA insertion on X-axis , Systolic BP readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.
we can clearly see a negative trend/slope indicating a fall with passage of Time. The difference between two Drug Group appears significant,However the Fall in Systolic BP with Time is moderated by effect of Drugs as we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Systolic BP across groups varies with Time. . we decided to explore this intuitive graphical relationship with formal statistical tests.
.Two way repeated measures ANOVA was done to assess difference between average Systolic BP across Stages/time of LMA Insertion group and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of value within t Stages/time of LMA Insertion was affected by Drug. Inter group comparison of average difference between SBP of 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 50.08,p= 0.0001. Intra group comparison of average difference between value of SBP across Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 130.38,p= 0.0001. Interaction of SBP within Stages/time of LMA Insertion with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 133.66,p= 0.0001
Since Inter group average differences of Systolic BP between 2 DRUG Groups was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -12.61+-1.78, pvalue= <0.001. Table of means/standard errors and contrasts is presented below.
Table 6. Average Systolic BP, standard error and 95% Confidence limits in DRUG Groups
| Drug | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| FENTOFOL | 112.418 | 1.26 | 109.910 | 114.926 |
| KETOFOL | 125.025 | 1.26 | 122.517 | 127.533 |
Table 7. Average Contrast in Systolic BP within DRUG Groups
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| FENTOFOL - KETOFOL | -12.607 | 1.781 | 78 | -7.077 | 0 |
We also wanted to look for a trend in our Stages/time of LMA Insertion group since it had a time varying component .We found a significant Negative linear trend in intra-group difference with Stages/time of LMA Insertion, (-67.29+-2.96) , p value= <0.001. It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in systolic BP with Stages/time of LMA Insertion (p value= <0.001). The non-linear trend is apparent in plot as well where we see that maximum fall occurs post Propofol in Both groups,Followed by a rise. In KetoFol group Systolic BP remains relatively steady. Table of means/standard errors and contrasts is presented below.
Table 8. Average Systolic BP, standard error and 95% Confidence limits in various Satges Of LMA Insertion
| time | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| Before.Induction | 127.138 | 1.03 | 125.101 | 129.174 |
| After.Intervention | 127.800 | 1.03 | 125.763 | 129.837 |
| After.propofol | 115.588 | 1.03 | 113.551 | 117.624 |
| After.LMA | 119.100 | 1.03 | 117.063 | 121.137 |
| 1.min | 111.638 | 1.03 | 109.601 | 113.674 |
| 2.min | 115.688 | 1.03 | 113.651 | 117.724 |
| 3.min | 114.100 | 1.03 | 112.063 | 116.137 |
Table 9. Average Contrast in Systolic BP within all Subgroups of Stages of LMA Insertion
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| Before.Induction - After.Intervention | -0.662 | 0.79 | 468 | -0.839 | 0.981 |
| Before.Induction - After.propofol | 11.550 | 0.79 | 468 | 14.625 | 0.001 |
| Before.Induction - After.LMA | 8.038 | 0.79 | 468 | 10.177 | 0.001 |
| Before.Induction - 1.min | 15.500 | 0.79 | 468 | 19.626 | 0.001 |
| Before.Induction - 2.min | 11.450 | 0.79 | 468 | 14.498 | 0.001 |
| Before.Induction - 3.min | 13.038 | 0.79 | 468 | 16.508 | 0.001 |
| After.Intervention - After.propofol | 12.213 | 0.79 | 468 | 15.463 | 0.001 |
| After.Intervention - After.LMA | 8.700 | 0.79 | 468 | 11.016 | 0.001 |
| After.Intervention - 1.min | 16.163 | 0.79 | 468 | 20.465 | 0.001 |
| After.Intervention - 2.min | 12.112 | 0.79 | 468 | 15.337 | 0.001 |
| After.Intervention - 3.min | 13.700 | 0.79 | 468 | 17.347 | 0.001 |
| After.propofol - After.LMA | -3.513 | 0.79 | 468 | -4.448 | 0.001 |
| After.propofol - 1.min | 3.950 | 0.79 | 468 | 5.001 | 0.001 |
| After.propofol - 2.min | -0.100 | 0.79 | 468 | -0.127 | 1 |
| After.propofol - 3.min | 1.487 | 0.79 | 468 | 1.883 | 0.492 |
| After.LMA - 1.min | 7.463 | 0.79 | 468 | 9.449 | 0.001 |
| After.LMA - 2.min | 3.413 | 0.79 | 468 | 4.321 | 0.001 |
| After.LMA - 3.min | 5.000 | 0.79 | 468 | 6.331 | 0.001 |
| 1.min - 2.min | -4.050 | 0.79 | 468 | -5.128 | 0.001 |
| 1.min - 3.min | -2.463 | 0.79 | 468 | -3.118 | 0.032 |
| 2.min - 3.min | 1.587 | 0.79 | 468 | 2.010 | 0.41 |
Figure 4 Trace-Plot Of variation in Diastolic BP with Time in FentoFol and Ketofol groups
This is a trace-plot of variation in Diastolic BP (on Y axis) with passage of of time of LMA insertion on X-axis , Diastolic BP readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.
we can clearly see a negative trend/slope indicating a fall with passage of Time. The difference between two Drug Group appears significant,However the Fall in Diastolic BP with Time is moderated by effect of Drugs as we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Diastolic BP across groups varies with Time. . we decided to explore this intuitive graphical relationship with formal statistical tests.
Two way repeated measures ANOVA was done to assess difference between average value of DBP across Stages/time of LMA Insertion and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of DBP within Stages/time of LMA Insertion time was affected by Drug. Inter group comparison of average difference of DBP between 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 27.91,p= 0.0001. Intra group comparison of average difference between DBP across Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 117.71,p= 0.0001. Interaction of DBP within Stages/time of LMA Insertion with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 32.47,p= 0.0001
Since Intra group average differences of value between 2 DRUGS was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -5.6+-1.06, pvalue= <0.001
Table 10. Average Diastolic BP, standard error and 95% Confidence limits in DRUG Groups
| Drug | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| FENTOFOL | 62.029 | 0.749 | 60.537 | 63.520 |
| KETOFOL | 67.625 | 0.749 | 66.134 | 69.116 |
Table 11. Average Contrast in Diastolic BP within DRUG Groups
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| FENTOFOL - KETOFOL | -5.596 | 1.059 | 78 | -5.283 | 0 |
We also wanted to look for a trend in our time group since it had a time varying component .We found a significant Negative linear trend in intra-group difference with Stages/time of LMA Insertion , (-24.72+-1.6, p value= <0.001). It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in Diastolic BP with Time (p value= <0.001). The non-linear trend is apparent in plot as well where we see that maximum fall occurs post Propofol in Both groups( though lesser as compared to Systolic BP) ,Followed by a rise. In KetoFol group Diastolic BP remains relatively steady. Table of means/standard errors and contrasts is presented below.
Table 12. Average Diastolic BP, standard error and 95% Confidence limits in various Satges Of LMA Insertion
| time | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| Before.Induction | 70.113 | 0.599 | 68.927 | 71.298 |
| After.Intervention | 67.388 | 0.599 | 66.202 | 68.573 |
| After.propofol | 64.863 | 0.599 | 63.677 | 66.048 |
| After.LMA | 60.875 | 0.599 | 59.690 | 62.060 |
| 1.min | 61.713 | 0.599 | 60.527 | 62.898 |
| 2.min | 62.975 | 0.599 | 61.790 | 64.160 |
| 3.min | 65.863 | 0.599 | 64.677 | 67.048 |
Table 13. Average Contrast in Diatolic BP within all Subgroups of Stages of LMA Insertion
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| Before.Induction - After.Intervention | 2.725 | 0.427 | 468 | 6.385 | 0.001 |
| Before.Induction - After.propofol | 5.250 | 0.427 | 468 | 12.302 | 0.001 |
| Before.Induction - After.LMA | 9.237 | 0.427 | 468 | 21.645 | 0.001 |
| Before.Induction - 1.min | 8.400 | 0.427 | 468 | 19.683 | 0.001 |
| Before.Induction - 2.min | 7.137 | 0.427 | 468 | 16.725 | 0.001 |
| Before.Induction - 3.min | 4.250 | 0.427 | 468 | 9.959 | 0.001 |
| After.Intervention - After.propofol | 2.525 | 0.427 | 468 | 5.917 | 0.001 |
| After.Intervention - After.LMA | 6.512 | 0.427 | 468 | 15.260 | 0.001 |
| After.Intervention - 1.min | 5.675 | 0.427 | 468 | 13.298 | 0.001 |
| After.Intervention - 2.min | 4.412 | 0.427 | 468 | 10.339 | 0.001 |
| After.Intervention - 3.min | 1.525 | 0.427 | 468 | 3.573 | 0.007 |
| After.propofol - After.LMA | 3.987 | 0.427 | 468 | 9.344 | 0.001 |
| After.propofol - 1.min | 3.150 | 0.427 | 468 | 7.381 | 0.001 |
| After.propofol - 2.min | 1.888 | 0.427 | 468 | 4.423 | 0.001 |
| After.propofol - 3.min | -1.000 | 0.427 | 468 | -2.343 | 0.226 |
| After.LMA - 1.min | -0.837 | 0.427 | 468 | -1.962 | 0.44 |
| After.LMA - 2.min | -2.100 | 0.427 | 468 | -4.921 | 0.001 |
| After.LMA - 3.min | -4.988 | 0.427 | 468 | -11.687 | 0.001 |
| 1.min - 2.min | -1.263 | 0.427 | 468 | -2.958 | 0.05 |
| 1.min - 3.min | -4.150 | 0.427 | 468 | -9.724 | 0.001 |
| 2.min - 3.min | -2.888 | 0.427 | 468 | -6.766 | 0.001 |
Figure 5 Trace-Plot Of variation in Pulse Rate with Time in FentoFol and Ketofol groups
This is a trace-plot of variation in Pulse Rate (on Y axis) with passage of of time of LMA insertion on X-axis , Mean Pulse Rate readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . The connected points across the trace represent the mean readings in two groups and Box Plots represents Distribution of Pulse Rates in two groups.
we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Pulse Rate across groups varies with Time. Pulse Rate at end of 3 minutes post LMA insertion appears higher in Ketofol Group than Baseline. we decided to explore this intuitive graphical relationship with formal statistical tests.
wo way repeated measures ANOVA was done to assess difference between average value of Pulse rate in Stages/time of LMA Insertion and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of value within time was affected by Drug.
Inter group comparison of average difference between Pulse Rate of 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 70.38,p= 0.0001. Intra group comparison of average difference between Pulse rate across Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 195.74,p= 0.0001. Interaction of Pulse rate within Stages/time of LMA Insertion with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 71.44,p= 0.0001
Since Intra group average differences of Pulse Rate between 2 Drugs was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -14.97+-1.78, pvalue= <0.001
Table 14. Average Pulse Rate, standard error and 95% Confidence limits in DRUG Groups
| Drug | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| FENTOFOL | 67.150 | 1.262 | 64.638 | 69.662 |
| KETOFOL | 82.118 | 1.262 | 79.606 | 84.630 |
Table 15. Average Contrast in Pulse Rate within DRUG Groups
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| FENTOFOL - KETOFOL | -14.968 | 1.784 | 78 | -8.389 | 0 |
We also wanted to look for a trend in Pulse rate in Stages/time of LMA Insertion since it had a time varying component .We found a non-significant linear trend in intra-group difference with time , (-5.35+-2.96, p value= 0.071). It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in Pulse Rate with Time (p value= <0.001). The non-linear trend is apparent in plot as well(Clear rise post LMA insertion in both groups followed by subsequent Fall) and it overwhems a linear trend unlike Systolic and Diastolic BP variation where linear trend was visible.. Table of means/standard errors and contrasts is presented below.
Table 16. Average Pulse Rate, standard error and 95% Confidence limits in various Satges Of LMA Insertion
| time | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| Before.Induction | 71.600 | 1.031 | 69.561 | 73.639 |
| After.Intervention | 73.213 | 1.031 | 71.173 | 75.252 |
| After.propofol | 69.113 | 1.031 | 67.073 | 71.152 |
| After.LMA | 90.538 | 1.031 | 88.498 | 92.577 |
| 1.min | 78.125 | 1.031 | 76.086 | 80.164 |
| 2.min | 72.688 | 1.031 | 70.648 | 74.727 |
| 3.min | 67.163 | 1.031 | 65.123 | 69.202 |
Table 17. Average Contrast in Pulse Rate within all Subgroups of Stages of LMA Insertion
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| Before.Induction - After.Intervention | -1.613 | 0.79 | 468 | -2.041 | 0.39 |
| Before.Induction - After.propofol | 2.487 | 0.79 | 468 | 3.149 | 0.029 |
| Before.Induction - After.LMA | -18.938 | 0.79 | 468 | -23.973 | 0.001 |
| Before.Induction - 1.min | -6.525 | 0.79 | 468 | -8.260 | 0.001 |
| Before.Induction - 2.min | -1.088 | 0.79 | 468 | -1.377 | 0.814 |
| Before.Induction - 3.min | 4.437 | 0.79 | 468 | 5.617 | 0.001 |
| After.Intervention - After.propofol | 4.100 | 0.79 | 468 | 5.190 | 0.001 |
| After.Intervention - After.LMA | -17.325 | 0.79 | 468 | -21.932 | 0.001 |
| After.Intervention - 1.min | -4.913 | 0.79 | 468 | -6.219 | 0.001 |
| After.Intervention - 2.min | 0.525 | 0.79 | 468 | 0.665 | 0.994 |
| After.Intervention - 3.min | 6.050 | 0.79 | 468 | 7.659 | 0.001 |
| After.propofol - After.LMA | -21.425 | 0.79 | 468 | -27.122 | 0.001 |
| After.propofol - 1.min | -9.013 | 0.79 | 468 | -11.409 | 0.001 |
| After.propofol - 2.min | -3.575 | 0.79 | 468 | -4.526 | 0.001 |
| After.propofol - 3.min | 1.950 | 0.79 | 468 | 2.469 | 0.173 |
| After.LMA - 1.min | 12.413 | 0.79 | 468 | 15.713 | 0.001 |
| After.LMA - 2.min | 17.850 | 0.79 | 468 | 22.596 | 0.001 |
| After.LMA - 3.min | 23.375 | 0.79 | 468 | 29.591 | 0.001 |
| 1.min - 2.min | 5.438 | 0.79 | 468 | 6.883 | 0.001 |
| 1.min - 3.min | 10.963 | 0.79 | 468 | 13.878 | 0.001 |
| 2.min - 3.min | 5.525 | 0.79 | 468 | 6.994 | 0.001 |
Figure 6 Trace-Plot Of variation in Mean Arterial BP with Time in FentoFol and Ketofol groups
This is a trace-plot of variation in Mean Arterial Pressure (on Y axis) with passage of of time of LMA insertion on X-axis , MAP readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.
we can clearly see a negative trend/slope indicating a fall with passage of Time. The difference between two Drug Group appears significant,However the Fall in MAP with Time is moderated by effect of Drugs as we can see different slopes of variation with Time between Fentofol and KetoFol groups indicating average difference in Diastolic BP across groups varies with Time. MAP in KetoFol group appear to be relatively stable . we decided to explore this intuitive graphical relationship with formal statistical tests.
Two way repeated measures ANOVA was done to assess difference between average value of MAP across Stages/time of LMA Insertion and if there was inter-group differences between 2 Drugs . An interaction test was also conducted to see if inter-group variation of MAP within Stages/time of LMA Insertion was affected by Drug. Inter group comparison of average difference between MAP of 2 Drugs was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(1, 78) = 76.19,p= 0.0001. Intra group comparison of average difference between MAP with Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 213.82,p= 0.0001. Interaction of MAP within time with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 142.29,p= 0.0001
Since Intra group average differences of MAP between 2 Drugs was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -7.93+-0.91, pvalue= <0.001
Table 18. Average MAP, standard error and 95% Confidence limits in DRUG Groups
| Drug | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| FENTOFOL | 78.825 | 0.643 | 77.545 | 80.104 |
| KETOFOL | 86.758 | 0.643 | 85.479 | 88.038 |
Table 19. Average Contrast in MAP within DRUG Groups
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| FENTOFOL - KETOFOL | -5.596 | 1.059 | 78 | -5.283 | 0 |
We also wanted to look for a trend of MAP in Stages/time of LMA Insertion our time group since it had a time varying component .We found a significant Negative linear trend in intra-group difference with time ,() -38.91+-1.44, p value= <0.001).It was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in MAP with Time (p value= <0.001). The non-linear trend is apparent in plot as well where we see that maximum fall occurs post Propofol in Both groups( and MAP continues to fall in FEntoFol Group ,Followed by a late) rise. In KetoFol group MAP remains relatively steady. Table of means/standard errors and contrasts is presented below.
Table 20. Average MAP, standard error and 95% Confidence limits in various Satges Of LMA Insertion
| time | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| Before.Induction | 89.12 | 0.52 | 88.09 | 90.15 |
| After.Intervention | 87.53 | 0.52 | 86.50 | 88.55 |
| After.propofol | 81.77 | 0.52 | 80.74 | 82.80 |
| After.LMA | 80.28 | 0.52 | 79.26 | 81.31 |
| 1.min | 78.35 | 0.52 | 77.33 | 79.38 |
| 2.min | 80.55 | 0.52 | 79.52 | 81.57 |
| 3.min | 81.94 | 0.52 | 80.91 | 82.97 |
Table 21. Average Contrast in MAP within all Subgroups of Stages of LMA Insertion
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| Before.Induction - After.Intervention | 1.596 | 0.385 | 468 | 4.141 | 0.001 |
| Before.Induction - After.propofol | 7.350 | 0.385 | 468 | 19.073 | 0.001 |
| Before.Induction - After.LMA | 8.838 | 0.385 | 468 | 22.934 | 0.001 |
| Before.Induction - 1.min | 10.766 | 0.385 | 468 | 27.939 | 0.001 |
| Before.Induction - 2.min | 8.575 | 0.385 | 468 | 22.253 | 0.001 |
| Before.Induction - 3.min | 7.179 | 0.385 | 468 | 18.631 | 0.001 |
| After.Intervention - After.propofol | 5.754 | 0.385 | 468 | 14.932 | 0.001 |
| After.Intervention - After.LMA | 7.242 | 0.385 | 468 | 18.793 | 0.001 |
| After.Intervention - 1.min | 9.171 | 0.385 | 468 | 23.798 | 0.001 |
| After.Intervention - 2.min | 6.979 | 0.385 | 468 | 18.112 | 0.001 |
| After.Intervention - 3.min | 5.583 | 0.385 | 468 | 14.490 | 0.001 |
| After.propofol - After.LMA | 1.488 | 0.385 | 468 | 3.861 | 0.002 |
| After.propofol - 1.min | 3.417 | 0.385 | 468 | 8.866 | 0.001 |
| After.propofol - 2.min | 1.226 | 0.385 | 468 | 3.180 | 0.026 |
| After.propofol - 3.min | -0.171 | 0.385 | 468 | -0.442 | 0.999 |
| After.LMA - 1.min | 1.929 | 0.385 | 468 | 5.006 | 0.001 |
| After.LMA - 2.min | -0.262 | 0.385 | 468 | -0.681 | 0.994 |
| After.LMA - 3.min | -1.658 | 0.385 | 468 | -4.303 | 0.001 |
| 1.min - 2.min | -2.191 | 0.385 | 468 | -5.686 | 0.001 |
| 1.min - 3.min | -3.587 | 0.385 | 468 | -9.309 | 0.001 |
| 2.min - 3.min | -1.396 | 0.385 | 468 | -3.623 | 0.006 |
Figure 7 Trace-Plot Of variation in Mean Arterial BP with Time in FentoFol and Ketofol groups
This is a trace-plot of variation in Respiratory Rate (on Y axis) with passage of of time of LMA insertion on X-axis , RR readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.
we can clearly see a positive trend/slope indicating a transient rise with passage of Time in both groups. The difference between two Drug Groups appears significant,we can also see different slopes of variation of Respiratory Rate with Time between Fentofol and KetoFol groups indicating average difference in RR across groups varies with Time. (Rise is more acute in KetoFol group and Fall as well) we decided to explore this intuitive graphical relationship with formal statistical tests.
Two way repeated measures ANOVA was done to assess difference between average Respiratory Rate with and if there was inter-group differences between Drug . An interaction test was also conducted to see if inter-group variation of Respiratory Rate across Stages/time of LMA Insertion was affected by Drug. Since Sphericity (homogeneity of variance between pairs of intra-group comparisons) assumption was not met.Greenhouse-Geisser Correction was applied . Inter group comparison of average difference between Respiratory rate of Drugs(Ketofol and FentoFol) was significant with a p value of 0.0003 . In Formal statistical notation it is expressed as F(1, 78) = 14.62,p= 0.0003. Intra group comparison of average difference between Respiratory Rate within Stages/time of LMA Insertion was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 208.36,p= 0.0001. Interaction of Respiratory Rate within time with Drug was significant with a p value of 0.0001 . In Formal statistical notation it is expressed as F(6, 468) = 25.59,p= 0.0001
Since Intra group average differences of Respiratory Rate between Drug groups was significant. We performed a test of contrasts. The Inter-group difference between FENTOFOL - KETOFOL was significant with mean difference of -0.74+-0.19, pvalue= <0.001
Table 22. Average Respiratory Rate, standard error and 95% Confidence limits in DRUG Groups
| Drug | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| FENTOFOL | 12.279 | 0.137 | 12.006 | 12.551 |
| KETOFOL | 13.018 | 0.137 | 12.746 | 13.290 |
Table 23. Average Contrast in Respiratory Rate between DRUG Groups
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| FENTOFOL - KETOFOL | -0.739 | 0.193 | 78 | -3.823 | 0 |
we also wanted to look for a trend in Respiratory Rate across Stages/time of LMA Insertion since it had a time varying component .We found a significant positive linear trend in intra-group difference in Respiratory with time , 2.69+-0.44, p value= <0.001.t was qualified by a significant quadratic,cubic and degree 5 and 6 trends indicating a non-linear variation in Respiratory Rate with Time (p value= <0.001).Table of means/standard errors and contrasts is presented below.
Table 24. Average RR, standard error and 95% Confidence limits in various Satges Of LMA Insertion
| time | Mean | Standard_Error | lower.CL | upper.CL |
|---|---|---|---|---|
| Before.Induction | 11.94 | 0.12 | 11.69 | 12.18 |
| After.Intervention | 11.85 | 0.12 | 11.61 | 12.09 |
| After.propofol | 11.89 | 0.12 | 11.64 | 12.13 |
| After.LMA | 14.78 | 0.12 | 14.53 | 15.02 |
| 1.min | 13.88 | 0.12 | 13.63 | 14.12 |
| 2.min | 12.43 | 0.12 | 12.18 | 12.67 |
| 3.min | 11.79 | 0.12 | 11.54 | 12.03 |
Table 25. Average Contrast in Respiratory Rate within all Subgroups of Stages of LMA Insertion
| contrast | estimate | SE | df | t.ratio | p.value |
|---|---|---|---|---|---|
| Before.Induction - After.Intervention | 0.087 | 0.117 | 468 | 0.749 | 0.989 |
| Before.Induction - After.propofol | 0.050 | 0.117 | 468 | 0.428 | 1 |
| Before.Induction - After.LMA | -2.838 | 0.117 | 468 | -24.276 | 0.001 |
| Before.Induction - 1.min | -1.938 | 0.117 | 468 | -16.576 | 0.001 |
| Before.Induction - 2.min | -0.488 | 0.117 | 468 | -4.171 | 0.001 |
| Before.Induction - 3.min | 0.150 | 0.117 | 468 | 1.283 | 0.859 |
| After.Intervention - After.propofol | -0.037 | 0.117 | 468 | -0.321 | 1 |
| After.Intervention - After.LMA | -2.925 | 0.117 | 468 | -25.025 | 0.001 |
| After.Intervention - 1.min | -2.025 | 0.117 | 468 | -17.325 | 0.001 |
| After.Intervention - 2.min | -0.575 | 0.117 | 468 | -4.919 | 0.001 |
| After.Intervention - 3.min | 0.063 | 0.117 | 468 | 0.535 | 0.998 |
| After.propofol - After.LMA | -2.887 | 0.117 | 468 | -24.704 | 0.001 |
| After.propofol - 1.min | -1.988 | 0.117 | 468 | -17.004 | 0.001 |
| After.propofol - 2.min | -0.537 | 0.117 | 468 | -4.599 | 0.001 |
| After.propofol - 3.min | 0.100 | 0.117 | 468 | 0.856 | 0.979 |
| After.LMA - 1.min | 0.900 | 0.117 | 468 | 7.700 | 0.001 |
| After.LMA - 2.min | 2.350 | 0.117 | 468 | 20.105 | 0.001 |
| After.LMA - 3.min | 2.988 | 0.117 | 468 | 25.560 | 0.001 |
| 1.min - 2.min | 1.450 | 0.117 | 468 | 12.405 | 0.001 |
| 1.min - 3.min | 2.088 | 0.117 | 468 | 17.860 | 0.001 |
| 2.min - 3.min | 0.638 | 0.117 | 468 | 5.454 | 0.001 |
Figure 8 Trace-Plot Of variation in Oxygen Saturation with Time in FentoFol and Ketofol groups
This is a trace-plot of variation in Oxygen saturation (on Y axis) with passage of of time of LMA insertion on X-axis , Oxygen Saturation readings of FentoFol and Ketofol Groups across various stages are connected by distinct colored trace-line . Individual readings have been plotted on graph and points have been jittered for better clarity . The raw data points representing two groups have different shapes as indicated in the legend. The colored points across the trace represent the mean readings in two groups and whiskers represent Standard error of measurements.
We cant see a definite trend in variation of oxygen Saturation as there is lot of random variation. we decided to explore this intuitive graphical relationship with formal statistical tests.
Two way repeated measures ANOVA was done to assess difference between average Saturation with passage of of time and if there was differences in oxygen saturation between 2 Drugs . An interaction test was also conducted to see if inter-group variation of Oxygen Saturation within Stages/time of LMA Insertion was affected by Drug. Since Sphericity (homogeneity of variance between pairs of intra-group comparisons) assumption was not met.Greenhouse-Geisser Correction was applied Inter group comparison of average difference between Oxygen saturation of 2 Drugs was non-significant with a p value of 0.190 . In Formal statistical notation it is expressed as F(1, 78) = 1.78,p= 0.190. Intra group comparison of average difference between value of time was non-significant with a p value of 0.830 . Since There was no significant difference within Drug groups or with passage of time (p=0.7) we didnt explore it further.
Figure 9 Boxplot Of Distribution Of LMA Insertion Score in our Population
In this Figure we see Box plot of LMA_INSERTION_SCORE in 2 sub-groups of DRUG : FENTOFOL and KETOFOL respectively .The individual jittered data points of LMA_INSERTION_SCORE are overlaid over transparent Boxplot for better visualisation. We see distribution of data in individual sub-groups of DRUG based on these box-plots. The lower edge of box plot represents -first quartile (Q1), Horizontal bar represents the median, Upper edge represnts third quartile (Q3), Two black lines (whiskers) emanating from box-plots signify range of non-outlier data for the particular sub-group. Lower whisker represents minimum(Q1- 1.5 interquartile range) non-outlier limit of LMA_INSERTION_SCORE and upper whisker represnts maximum(Q1+1.5interquartile range) of LMA_INSERTION_SCORE .Any data beyond whiskers of box-plots represents outliers in the sub-groups The big brown point in the box-plots represents mean LMA_INSERTION_SCORE of 2 groups and it has been annotated in the figure itself . Summary Statistics of the groups is presented in table below
Table 26 Summary Table Of LMA INSERTION SCORE within Groups
| Group | n | Mean | SD | Median | Minimum | Maximum |
|---|---|---|---|---|---|---|
| FENTOFOL | 40 | 6.925 | 0.859 | 7 | 6 | 9 |
| KETOFOL | 40 | 7.350 | 0.893 | 7 | 6 | 9 |
We formally performed a Welch’s independent Sample T test between Two Groups. The mean in FENTOFOL [ 6.9 ± 0.85 ] was significantly lower than KETOFOL Group [ 7.35 ± 0.89] . The mean difference was 0.425 . The p value was <0.03 . The t statistic was 2.116 and degree of freedom of the Welch unpaired two-sample t test was 77.88 .In Formal statistical notation this result is expressed as : t(77.88) = 2.16, p= 0.0331. The detailed statistical parameters of T test are given in table below.
TABLE 27
| variable | group1 | group2 | statistic | df | p |
|---|---|---|---|---|---|
| LMA_INSERTION_SCORE | FENTOFOL | KETOFOL | -2.17 | 77.88 | 0.03 |
Figure 10 Distribution Of APNEA IN TWO GROUPS
The Grouped Pie chart above represents individual counts representing frequency of APNEA categories Apnea and No_Apnea in categories FENTOFOL and KETOFOL . Subgroup No_Apnea has highest percentage 31/40 ( 78 % ) in group FENTOFOL . Subgroup No_Apnea has highest percentage 40/40 ( 100 % ) in group KETOFOL . To formally check for association between groups we performed pearson chi-square test .
we found a Significant association between APNEA and DRUG. The chi-square statistic was 8.01 . The degree of freedom was 1 and P value was <0.001 .Contingency and Proportion table are shown below
Table 28
| DRUG | APNEA | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| FENTOFOL | Apnea | 35 | 35/40 ( 87.5 %) | 74.75% - 95.07% |
| FENTOFOL | No_Apnea | 5 | 5/40 ( 12.5 %) | 4.93% - 25.25% |
| KETOFOL | No_Apnea | 40 | 40/40 ( 100 %) | 93.95% - 100% |
Figure 11 Distribution Of ADDITIONAL PROPOFOL REQUIREMENT IN TWO GROUPS
The Grouped Pie chart above represents individual counts representing frequency of PROPOFOL REQUIREment categories in categories FENTOFOL and KETOFOL . No Propofol requirement was seen in 29/40 ( 72.5 % ) in group FENTOFOL .No Propofol requirement was seen in 37/40 ( 92.5 % ) in group KETOFOLL . To formally check for association between groups we performed pearson chi-square test .
we found a Significant association between ADDITIONAL_PROPOFOL_REQUIRED and DRUG. The chi-square statistic was 4.24 . The degree of freedom was 1 and P value was 0.04 .Contingency and Proportion table are shown below
Table 29
| DRUG | ADDITIONAL_PROPOFOL_REQUIRED | n | value | 95 % Confidence Interval |
|---|---|---|---|---|
| FENTOFOL | No | 29 | 29/40 ( 72.5 %) | 57.45% - 84.42% |
| FENTOFOL | Yes | 11 | 11/40 ( 27.5 %) | 15.58% - 42.55% |
| KETOFOL | No | 37 | 37/40 ( 92.5 %) | 81.32% - 97.84% |
| KETOFOL | Yes | 3 | 3/40 ( 7.5 %) | 2.16% - 18.68% |
Table 30
| FENTOFOL | KETOFOL | |
|---|---|---|
| No | 29 | 37 |
| Yes | 11 | 3 |